Patents Assigned to SanRX Pharmaceuticals, Inc.
  • CALCIUM FOLATE (CAFOLATE) AND THERAPEUTIC METHODS BASED THEREON
    Publication number: 20150010509
    Abstract: Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the administration of CaFolate. In one embodiment is a method of treating cancer comprising administration of CaFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of CaFolate.
    Type: Application
    Filed: January 29, 2013
    Publication date: January 8, 2015
    Applicant: SanRx Pharmaceuticals, Inc.
    Inventor: Phillip Moheno
  • Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
    Patent number: 7662820
    Abstract: Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 16, 2010
    Assignee: SanRX Pharmaceuticals, Inc.
    Inventors: Phillip Moheno, Wolfgang Pfleiderer
  • Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
    Publication number: 20080166355
    Abstract: Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 10, 2008
    Applicant: SanRx Pharmaceuticals, Inc.
    Inventors: Phillip Moheno, Wolfgang Pfleiderer